|
 |
| home > pmps > spring 2003 > controlled delivery technology in nutraceutical applications: a user's perspective |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Dietary supplements are now widely used by consumers to complement a healthy balanced diet. However, in a highly competitive marketplace, key points of differentiation can be obtained by using the latest technology to produce ingredients that offer consumers dietary supplements that have improved efficiency and convenience. One of the most exciting recent developments in dietary supplement ingredient manufacture is controlled delivery technology or CDTTM. Materials science, colloid chemistry and biopharmaceutics have been applied to develop monolithic matrix systems collectively referred to as 'self-correcting matrix delivery systems'. These systems control the release of a precise quantity of active ingredient over a pre-determined timeframe. In this article, we review the science behind CDT, discuss its comparative benefits and highlight how this technology has been successfully applied.
What is Controlled Release Technology?
A platform of patented technologies has been developed that can be applied to compounds with a wide range of properties and characteristics. CDT is based upon a simple hydrophilic swellable matrix model, but it incorporates a number of geometrical modifications. It uses in situ ionic associations between the active compound and the ionic excipients to control the diffusion of a precise quantity of either single or multiple active ingredients from the supplement product over a predetermined time period.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EMBALLAGE 2008. World Packaging Exhibition
16-21 November 2008, Paris-Nord Villepinte - France
“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
